| Healthy controls (n = 103) | COPD with CV comorbidity (n = 47) | COPD without CV comorbidity (n = 55) | p Value | |
| Heart rate (bpm) | 67 (1) | 69 (2) | 69 (2) | 0.621 |
| Peripheral sBP (mm Hg) | 132 (2) | 149 (3.5) | 146 (3) | 0.000 |
| Peripheral dBP (mm Hg) | 78 (1) | 82 (2) | 83 (2) | 0.019 |
| Peripheral MAP (mm Hg) | 96 (1) | 105 (2) | 104 (2) | 0.000 |
| Peripheral PP (mm Hg) | 54 (1) | 68 (3) | 63 (2) | 0.000 |
| Central sBP (mm Hg) | 123 (2) | 137 (3) | 134 (3) | 0.000 |
| Central dBP (mm Hg) | 79 (1) | 83 (2) | 84 (2) | 0.011 |
| Central MAP (mm Hg) | 99 (1) | 105 (2) | 104 (2) | 0.045 |
| Central PP (mm Hg) | 45 (1) | 54 (3) | 51 (2) | 0.001 |
| Augmentation pressure (mm Hg) | 14 (1) | 17 (1) | 16 (1) | 0.016 |
| Augmentation index (%) | 30 (1) | 31 (2) | 31 (1) | 0.628 |
| Time to reflection (ms) | 137 (2) | 131 (2) | 131 (2) | 0.015 |
Values are mean (SEM).
Groups compared with ANOVA.
COPD, chronic obstructive pulmonary disease; dBP, diastolic blood pressure; MAP, mean arterial pressure; PP, pulse pressure; sBP, systolic blood pressure.